Transient hyperphosphatemia : a benign laboratory disorder in a boy with Gitelman syndrome

A hiperfosfatasemia transitória benigna da infância (HTBI) é caracterizada por elevação transitória da atividade da fosfatase alcalina sérica (S-ALP), predominantemente em sua isoforma óssea ou hepática, em crianças com menos de cinco anos de idade. Não há sinais de patologia óssea metabólica ou hepatopatia correspondentes ao aumento da S-ALP, e Hiperfosfatemia transitória: uma alteração laboratorial benigna em um menino com síndrome de Gitelman

Transient hyperphosphatasemia of infancy and early childhood (THI) is characterized by transiently increased activity of serum alkaline phosphatase (S-ALP), predominantly its bone or liver isoform, in children under five years of age.There are no signs of metabolic bone disease or hepatopathy corresponding with the increased S-ALP.THI is benign disorder, rather laboratory than clinical disorder, which is usually accidentally detected in both healthy and sick children.When encountered in a child with either chronic bone, liver or kidney disease, it might concern the physician.We present a three year old boy with genetically confirmed Gitelman syndrome where THI was detected accidentally during periodic check-up.S-ALP peaked to 41.8 μkat/L, there were neither laboratory or clinical signs of liver or bone disease; the S-ALP dropped to normal value of 4 μkat/L 60 days later.Therefore, the patient fulfilled the criteria for THI.There were no further increases in S-ALP.

IntRoductIon
Transient hyperphosphatasemia of infancy and early childhood (THI) is characterized by transiently increased activity of serum alkaline phosphatase (S-ALP), predominantly its bone or liver isoform, in children under five years of age.There are no signs of metabolic bone disease or hepatopathy corresponding with the increased S-ALP, nor there is a disease common to all children with THI.
2][3] When encountered in a child with either chronic bone, liver or kidney disease, THI might concern the physician. 2,3se RepoRt Three year old boy with genetically confirmed Gitelman syndrome (three These criteria are not strict, as THI has been occassionaly observed even in adult individuals, and the duration of THI has repeatedly exceeded the time limit of 4 months. 2,3,7Furthermore, the electrophoretic evaluation of the ALP isoenzymes in THI is characterized by an atypical transient pattern of cathodal and anodal migrating fractions, bearing some similarities to the isoforms of bone and liver origin. 8The incidence of THI has been estimated at 2.8%. 91][12] The exact mechanism of THI is unclear, however, the impaired clearance of ALP from circulation is still considered as the most likely one. 1,2HI is generally considered a benign disorder.Furthemore, THI has to be differentiated from skeletal or liver diseases and can cause concern in patients with metabolic bone disorders. 13However, normal bone turnover has been observed in children with THI. 14,15In the presence of high S-ALP where basic biochemical markers (S-Ca, P, creatinine, ALT, AST) and radiograph of the wrist are normal, THI is the most likely diagnosis.Therefore, the children with THI should be spared from further diagnostic procedures (such as 99 Tc bone scans, repeated radiographs and blood draws) and the S-ALP can be re-assessed after 2-3 months. 2,16ur patient with genetically confirmed GS presented with high S-ALP, thus drawing some concern about disturbed bone metabolism due to possible mineral dysbalance that may occur in GS. 5,17 However, the normal values of S-Ca, P, Mg, U-Ca/U-cr and normal wrist X-ray ruled out this possibility and pointed to the diagnosis of THI, which was further confirmed by normalisation of S-ALP within two months.
In conclusion, we presented a case of THI in a boy with GS.This case met the criteria for THI, which is a benign condition with good prognosis.7][18] Children with THI should be spared from unnecessary early diagnostic procedures and therapeutic interventions.The monitoring of S-ALP on a monthly or two-monthly basis is recommended before any further diagnostic steps are undertaken.different mutations in SLC12A3 gene; c.2576T > C and c.2929C > T mutations considered as causal ones; mother: heterozygous carrier of mutation c.2567T > C; father: heterozygous carrier of mutation c.2929C > T), reported earlier, 4 presented for a periodic check-up in our out-patient clinic.He was receiving potassium supplementation (KCl tablets 3x1000 mg/day) and ACE inhibitor (enalapril; 1.25 mg/day).
He was doing well, without any clinical signs of psychomotor retardation or tendency to failure to thrive.The serum values of blood urea nitrogen (BUN), creatinine, potassium(S-K), sodium (S-Na), calcium (S-Ca), phosphate (S-P), magnesium (S-Mg), alaninaminotransferase (S-AST), apartate-aminotransferase (S-ALT) were within normal reference range, same as urinary concentrations of Ca, P, Mg and urinary calcium/creatinine ratio (U-Ca/U-cr).
However S-ALP was 41.8 μkat/L and this value was confirmed by the biochemical lab (normal agerelated value 1.8 -6.7 μkat/L).Wrist X-ray was normal without any signs of rickets.As there were neither laboratory or clinical signs of liver or bone disease, THI was considered as the most likely diagnosis.The boy was checked two months later, and at that time the S-ALP dropped to normal value of 4 μkat/L.Therefore the patient fulfilled the criteria for THI.There were no further increases in S-ALP and the patient, who is currently 10 years old, remains stable on the current medication of KCl and enalapril.

dIscussIon
Gitelman syndrome (GS) is a rare autosomal recessive salt-wasting nephropathy, characterized by hypokalemia, hypomagnesemia, hypocalciuria, metabolic alkalosis and low blood pressure.Typical clinical signs include fatigue, muscle weakness and muscle paralysis. 4,52][3] The definition of THI was delineated by Kraut in 1985 using the following criteria: 1) an age of less than 5 years; 2) variable, unrelated symptoms; 3) no bone or liver disease noted on physical examination or from laboratory investigations; 4) isoenzyme and isoform analysis showing elevations in both bone and liver aktivity; 5) a return to normal S-ALP values within four months. 6